COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,823 Articles (22,968 medRxiv, 8,855 bioRxiv)

Most recent first Previous |  Page 1789: Articles 17881-17890  | Next

Beliefs about Mask Efficacy and the Effect of Social Norms on Mask Wearing Intentions for COVID-19 Risk Reduction
Bokemper, S. E., Cucciniello, M., Rotesi, T. E., Pin, P., Malik, A. A., Willebrand, K., Paintsil, E. E., Omer, S. B., Huber, G. A., Melegaro, A.
10.1101/2021.03.02.21252722 — Posted: 2021-03-09
Vaccine effectiveness after 1st and 2nd dose of the BNT162b2 mRNA Covid-19 Vaccine in long-term care facility residents and healthcare workers - a Danish cohort study
Moustsen-Helms, I. R., Emborg, H.-D., Nielsen, J., Nielsen, K. F., Krause, T. G., Molbak, K., Moeller, K. L., Berthelsen, A.-S. N., Valentiner-Branth, P.
10.1101/2021.03.08.21252200 — Posted: 2021-03-09 Discussion: Onsite
Transmission of SARS-CoV-2 by children attending school. Interim report on an observational, longitudinal sampling study of infected children, contacts, and the environment
Cordery, R., Reeves, L., Zhou, J., Rowan, A. G., Watber, P., Rosadas, C., Crone, M. A., Freemont, P., Mosscrop, L., Cowley, A., Zelent, G., Bisset, K., LeBlond, H., Regmi, S., Mindlin, M., Lamagni, T., Barclay, W., Taylor, G. P., Sriskandan, S.
10.1101/2021.03.08.21252839 — Posted: 2021-03-09
Single-Arm, Open-Label Phase 2 Trial of Preemptive Methylprednisolone to Avert Progression to Respiratory Failure in High-Risk Patients with COVID-19
Cabanillas, F., Morales, J., Conde, J. G., Bertran-Pasarell, J., Fernandez, R., Hernandez-Silva, Y., Liboy, I., Bryan-Diaz, J., Arraut-Gonzalez, J.
10.1101/2021.03.08.21253117 — Posted: 2021-03-09
SARS-COV-2 antibody prevalence in patients on dialysis in the US in January 2021
Anand, S., Montez-Rath, M., Han, J., Cadden, L., Hunsader, P., Kerschmann, R., Beyer, P., Boyd, S. D., Garcia, P., Dittrich, M., Block, G. A., Parsonnet, J., Chertow, G. M.
10.1101/2021.03.07.21252786 — Posted: 2021-03-09
The plasmablast response to SARS-CoV-2 mRNA vaccination is dominated by non-neutralizing antibodies that target both the NTD and the RBD
Amanat, F., Thapa, M., Lei, T., Ahmed, S. M. S., Adelsberg, D. C., Carreno, J. M., Strohmeier, S., Schmitz, A. J., Zafar, S., Zhou, J. Q., Rijnink, W., Alshammary, H., Borcherding, N., Gonzalez Reiche, A., Srivastava, K., Sordillo, E. M., van Bakel, H., Turner, J. S., Bajic, G., Simon, V. M., Ellebedy, A. H., Krammer, F.
10.1101/2021.03.07.21253098 — Posted: 2021-03-09 Discussion: Onsite
A general computational framework for COVID-19 modelling, with applications to testing varied interventions in education environments
Moore, J. W., Lau, Z., Kaouri, K., Dale, T. C., Woolley, T. E.
10.1101/2021.03.08.21253122 — Posted: 2021-03-09
Predicting vaccine hesitancy from area-level indicators: A machine learning approach
Carrieri, V., Lagravinese, R., Resce, G.
10.1101/2021.03.08.21253109 — Posted: 2021-03-09
Effectiveness of a telerehabilitation program for COVID-19 survivors (TERECO) on exercise capacity, pulmonary function, lower limb muscle strength, and quality of life: a randomised controlled trial
Li, J., Xia, W., Zhan, C., Liu, S., Yin, Z., Wang, J., Chong, Y., Zheng, C., Fang, X., Cheng, W., Reinhardt, J. D.
10.1101/2021.03.08.21253007 — Posted: 2021-03-09
A quantitative risk estimation platform for indoor aerosol transmission of COVID-19
Parhizkar, H., Van Den Wymelenberg, K., Haas, C., Corsi, R.
10.1101/2021.03.05.21252990 — Posted: 2021-03-09

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).